News | January 21, 2025
Moderna announces updates on pandemic influenza program
The project will provide additional support for late-stage development and licensure of pre-pandemic mRNA-based vaccines
The project will provide additional support for late-stage development and licensure of pre-pandemic mRNA-based vaccines
_256_384.jpg)
Mesalazine is used to treat inflammatory bowel disease
This study will enrol 210 ALS patients and study doses of 50 mg and 75 mg Usnoflast versus placebo
The change is reflective of the company’s evolving vision aimed at further strengthening its global presence and a commitment to providing innovative solutions in the API and CDMO space
The company has paid an Interim Environmental Damage Compensation of Rs. 3.40 lakh to GPCB
This is the second Ready-To-Use Infusion bag (RTU Bags) ANDA drug product approved for Caplin Steriles
Based on ECHO Phase III trial results which showed more than 16 months of progression-free survival improvement vs. chemoimmunotherapy alone
Eculizumab is indicated for the treatment of patients with Paroxysmal Nocturnal Hemoglobinuria and atypical Hemolytic Uremic Syndrome
The brand Magtein by Threotech has a sales value of approximately US $438 million
Jubilant Cadista will submit an appropriate action plan to the USFDA on these observations
Subscribe To Our Newsletter & Stay Updated
